MRPL52 and breast carcinoma: Li et al. found that MRPL52 overexpression in breast cancer is induced by hypoxia-inducible factor 1 in response to hypoxic exposure, demonstrating its role in inhibiting apoptosis and promoting migration and invasion of hypoxic breast cancer cells (Li et al. 2021).